Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Offers Recommendations for HHS National Action Plan for Adverse Drug Event Prevention

Friday, October 04, 2013

On October 4, ASA offered official recommendations to the U.S. Department of Health and Human Services (HHS) for further development and refinement of the Draft National Action Plan for Adverse Drug Event Prevention.  ASA’s recommendations centered on pain medicine and opioid use, development of quality measures related to adverse drug events (ADEs) and the use of the Perioperative Surgical Home to coordinate care.

The Action Plan is an effort by the federal government to seek stakeholder engagement about ADEs. The plan lists two key objectives:  to "identify common, clinically significant, preventable, and measureable" ADEs and to "align the efforts of federal health agencies to reduce patient harms from those specific ADEs nationally."

Review ASA's recommendations.
Learn more about the HHS Draft National Action Plan for Adverse Drug Event Prevention.

« Back to Washington Alerts